One of the principal tools of personalized medicine is the use of companion diagnostics. In this first article in a two-part series on the opportunities and challenges that confront the rise of companion diagnostics, we use case studies to review the different roles that these products and services could play in the continued growth of the pharmaceutical industry. The article can be found here:
The Convergence of Financial and Societal Value, and What It Means
In this Marakon Commentary, Charlie Johnson and Christine Delivanis discuss how until very recently, the market and society more generally were less aware of...